POLYNEUROPATHY IN MALIGNANT DISEASE

POLYNEUROPATHY IN MALIGNANT DISEASE was reported 82 times

POLYNEUROPATHY IN MALIGNANT DISEASE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Provitamin D2 Compound [EPC] 16 0.0005
1 CD38-directed Cytolytic Antibody [EPC] 3 0.0005
2 Programmed Death Ligand-1 Blocker [EPC] 5 0.0002
3 Androgen Receptor Inhibitor [EPC] 17 0.0002
4 Microtubule Inhibitor [EPC] 32 0.0002
5 Programmed Death Receptor-1 Blocking Antibody [EPC] 17 0.0002
6 Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] 1 0.0002
7 Topoisomerase Inhibitor [EPC] 10 0.0001
8 RANK Ligand Inhibitor [EPC] 23 0.0001
9 Platinum-based Drug [EPC] 28 0.0001
10 Opioid Agonist [EPC] 18 0.0001
11 Alkylating Drug [EPC] 14 0.0001
12 Proteasome Inhibitor [EPC] 6 0.0001
13 Nucleoside Metabolic Inhibitor [EPC] 12 0.0000
14 Calcium [EPC] 5 0.0000
15 BCL-2 Inhibitor [EPC] 2 0.0000
16 Macrolide Antimicrobial [EPC] 1 0.0000
17 Erythropoiesis-stimulating Agent [EPC] 1 0.0000
18 Nonsteroidal Anti-inflammatory Drug [EPC] 18 0.0000
19 Arteriolar Vasodilator [EPC] 1 0.0000
20 Corticosteroid [EPC] 14 0.0000
21 Aromatase Inhibitor [EPC] 1 0.0000
22 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
23 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
24 alpha-Adrenergic Blocker [EPC] 1 0.0000
25 Thalidomide Analog [EPC] 3 0.0000
26 Loop Diuretic [EPC] 2 0.0000
27 Vitamin D [EPC] 1 0.0000
28 beta-Adrenergic Blocker [EPC] 1 0.0000
29 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
30 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
31 Vitamin B12 [EPC] 1 0.0000
32 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
33 Vitamin C [EPC] 1 0.0000
34 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
35 Insulin Analog [EPC] 1 0.0000
36 Kinase Inhibitor [EPC] 1 0.0000
37 Proton Pump Inhibitor [EPC] 1 0.0000